NPSP795
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NPSP795, covering 2016-12-21 to 2016-12-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations [Phase 2]